Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-25-015981
Filing Date
2025-06-06
Accepted
2025-06-06 16:16:43
Documents
2
Period of Report
2025-06-04

Document Format Files

Seq Description Document Type Size
1 form3-06062025_080638.html 3  
1 form3-06062025_080638.xml 3 1660
2 ex24-06062025_080639.htm EX-24 6987
  Complete submission text file 0001415889-25-015981.txt   10111
Mailing Address 350 BAY STREET SUITE 100 #6009 SAN FRANCISCO CA 94133
Business Address 350 BAY STREET SUITE 100 #6009 SAN FRANCISCO CA 94133 415-978-1200
FIBROGEN INC (Issuer) CIK: 0000921299 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O KARYOPHARM THERAPEUTICS INC. 85 WELLS AVENUE, SECOND FLOOR NEWTON MA 02459
Business Address
Kauffman Michael (Reporting) CIK: 0001364719 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36740 | Film No.: 251030887